Evaluation of the "Platform Model" for Staffing in Psychiatric and Psychosomatic Clinics

NCT ID: NCT05240105

Last Updated: 2022-02-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

5961 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-06-11

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the so-called platform model and its suitability to determine staffing in hospitals for psychosomatic medicine and psychotherapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of the study is to test the suitability of a structural model (so-called platform model) developed by a working group of various scientific societies and professional associations for staffing in psychosomatic medicine and psychotherapy. For this purpose, in three steps (1.) the four treatment clusters developed in the platform model will be quantified and empirically validated on the basis of the therapeutic services provided in health care practice; (2.) the current staffing for the four treatment clusters will be described ("as-is analysis"); and (3.) prototypical therapy plans will be developed as a basis for estimating the target staffing requirements. On this basis, a target staffing estimate will be made for all professional groups.

For the study, a total of 80 psychosomatic clinics from Germany will be randomly selected, belonging in equal parts to the groups of psychosomatic university clinics, psychosomatic specialist hospitals, and psychosomatic departments in somatic or in psychiatric hospitals. In addition, 20 day clinics are included. In these clinics, the structural framework conditions including staffing will be surveyed and the routine documentation of therapy units will be evaluated by cluster analysis in order to empirically validate the presumed treatment clusters and to describe the necessary staffing requirements.

The empirical examination and validation of the platform model, including the four assumed treatment clusters, has the potential to positively influence care practice in the long term by adjusting staffing levels in psychosomatic clinics to actual care requirements.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psychosomatic Medicine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Departments for Psychosomatic Medicine at University Clinics

no study interventions, observational group

no intervention, purely observational

Intervention Type OTHER

There will be no interventions. The study is purely observational and investigates differences in naturally occuring treatments at these four types of departments for Psychosomatic Medicine.

Clinics specialized in Psychosomatic Medicine

no study interventions, observational group

no intervention, purely observational

Intervention Type OTHER

There will be no interventions. The study is purely observational and investigates differences in naturally occuring treatments at these four types of departments for Psychosomatic Medicine.

Departments for Psychosomatic Medicine at general hospitals

no study interventions, observational group

no intervention, purely observational

Intervention Type OTHER

There will be no interventions. The study is purely observational and investigates differences in naturally occuring treatments at these four types of departments for Psychosomatic Medicine.

Departments for Psychosomatic Medicine at psychiatric hospitals

no study interventions, observational group

no intervention, purely observational

Intervention Type OTHER

There will be no interventions. The study is purely observational and investigates differences in naturally occuring treatments at these four types of departments for Psychosomatic Medicine.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

no intervention, purely observational

There will be no interventions. The study is purely observational and investigates differences in naturally occuring treatments at these four types of departments for Psychosomatic Medicine.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* belong to the predefined nationwide population of psychosomatic specialist clinics and departments
* randomly selected for inclusion in the study,
* the clinic management (head physician or comparable) agrees to participation in the study
* possibility of electronic recording of the qualified therapy units for all treating professional groups.


* patient treated in one of the selected clinics on the corresponding ward or day clinic
* at least 18 years old

Exclusion Criteria

* none
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Deutsches Krankenhausinstitut

UNKNOWN

Sponsor Role collaborator

DGPPN

UNKNOWN

Sponsor Role collaborator

DGKJP

UNKNOWN

Sponsor Role collaborator

DGPM

UNKNOWN

Sponsor Role collaborator

Forum für Gesundheitswirtschaft gGmbH

UNKNOWN

Sponsor Role collaborator

University Hospital Heidelberg

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Simone Jennissen

Study coordinator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Simone University Jennissen

Heidelberg, Baden-Wurttemberg, Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Simone U Jennissen, PhD

Role: CONTACT

004962215634620

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Simone U Jennissen, PhD

Role: primary

+4962215634620

Hans-Christoph Friederich, Prof.

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EPPIK

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.